Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 3827037, 10 pages
https://doi.org/10.1155/2017/3827037
Research Article

Prognostic Relevance and Function of MSX2 in Colorectal Cancer

1State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
2Clinical Immunology Center, Chinese Academy of Medical Science, Beijing 100730, China
3Department of Colorectal Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
4Department of Pharmacy, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
5Beijing Hospital, National Center of Gerontology, Beijing 100730, China

Correspondence should be addressed to Lianzhen Chen; moc.361@zlckjy and Jie Ma; moc.361@5691eijam

Received 24 October 2016; Accepted 1 December 2016; Published 12 February 2017

Academic Editor: Chun Gao

Copyright © 2017 Jiancheng Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Arnold, M. S. Sierra, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray, “Global patterns and trends in colorectal cancer incidence and mortality,” Gut, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Chen, R. Zheng, P. D. Baade et al., “Cancer statistics in China, 2015,” CA Cancer Journal for Clinicians, vol. 66, no. 2, pp. 115–132, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Y. Cheung, E. Y. Hui, C. H. Lee et al., “Impact of genetic loci identified in Genome-Wide Association Studies on diabetic retinopathy in Chinese patients with type 2 diabetes,” Investigative Ophthalmology & Visual Science, vol. 57, no. 13, pp. 5518–5524, 2016. View at Google Scholar
  4. F. B. Hu, J. E. Manson, M. J. Stampfer et al., “Diet, lifestyle, and the risk of type 2 diabetes mellitus in women,” New England Journal of Medicine, vol. 345, no. 11, pp. 790–797, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. J. E. Manson, M. J. Stampfer, G. A. Colditz et al., “Physical activity and incidence of non-insulin-dependent diabetes mellitus in women,” The Lancet, vol. 338, no. 8770, pp. 774–778, 1991. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Wu, C. Yu, H. Jiang et al., “Diabetes mellitus and the occurrence of colorectal cancer: an updated meta-analysis of cohort studies,” Diabetes Technology & Therapeutics, vol. 15, no. 5, pp. 419–427, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Singh, C. C. Earle, S. J. Bae et al., “Incidence of diabetes in colorectal cancer survivors,” Journal of the National Cancer Institute, vol. 108, no. 6, Article ID djv402, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Satokata, L. Ma, H. Ohshima et al., “Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation,” Nature Genetics, vol. 24, no. 4, pp. 391–395, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. J.-S. Shao, S.-L. Cheng, J. M. Pingsterhaus, N. Charlton-Kachigian, A. P. Loewy, and D. A. Towler, “Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals,” Journal of Clinical Investigation, vol. 115, no. 5, pp. 1210–1220, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Vattikuti and D. A. Towler, “Osteogenic regulation of vascular calcification: an early perspective,” American Journal of Physiology—Endocrinology and Metabolism, vol. 286, no. 5, pp. E686–E696, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. J. K. Snell-Bergeon, M. J. Budoff, and J. E. Hokanson, “Vascular calcification in diabetes: mechanisms and implications,” Current Diabetes Reports, vol. 13, no. 3, pp. 391–402, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C.-W. Chua, Y.-T. Chiu, H.-F. Yuen et al., “Differential expression of MSX2 in nodular hyperplasia, high-grade prostatic intraepithelial neoplasia and prostate adenocarcinoma,” APMIS, vol. 118, no. 12, pp. 918–926, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Satoh, S. Hamada, and T. Shimosegawa, “MSX2 in pancreatic tumor development and its clinical application for the diagnosis of pancreatic ductal adenocarcinoma,” Frontiers in Physiology, vol. 3, article no. 430, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Satoh, S. Hamada, K. Kimura et al., “Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells,” American Journal of Pathology, vol. 172, no. 4, pp. 926–939, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Ohta, K. Aoyagi, M. Fukaya et al., “Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers,” British Journal of Cancer, vol. 100, no. 2, pp. 389–398, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Zhai, A. Iura, S. Yeasmin et al., “MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma,” Oncogene, vol. 30, no. 40, pp. 4152–4162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Hamada, K. Satoh, M. Hirota et al., “Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line,” Journal of Cellular Physiology, vol. 213, no. 3, pp. 768–774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. T. D. Schmittgen and K. J. Livak, “Analyzing real-time PCR data by the comparative CT method,” Nature Protocols, vol. 3, no. 6, pp. 1101–1108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. Y.-L. Yao, J. Shao, C. Zhang et al., “Proliferation of colorectal cancer is promoted by two signaling transduction expression patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK,” PloS ONE, vol. 8, no. 10, Article ID e78086, 2013. View at Google Scholar · View at Scopus
  20. G. Dufourt, M.-J. Demers, D. Gagné et al., “Human intestinal epithelial cell survival and anoikis: differentiation state-distinct regulation and roles of protein kinase B/Akt isoforms,” Journal of Biological Chemistry, vol. 279, no. 42, pp. 44113–44122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Agarwal, M. G. Brattain, and S. Chowdhury, “Cell survival and metastasis regulation by Akt signaling in colorectal cancer,” Cellular Signalling, vol. 25, no. 8, pp. 1711–1719, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Foersch, T. Sperka, C. Lindner et al., “VEGFR2 signaling prevents colorectal cancer cell senescence to promote tumorigenesis in mice with colitis,” Gastroenterology, vol. 149, no. 1, pp. 177.e10–189.e10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. G. Jiang, T. Y. Li, D. N. Liu, and H. T. Zhang, “PI3K/Akt pathway involving into apoptosis and invasion in human colon cancer cells LoVo,” Molecular Biology Reports, vol. 41, no. 5, pp. 3359–3367, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-L. Xu, J.-Z. Wang, X.-P. Xia et al., “Rab11-FIP2 promotes colorectal cancer migration and invasion by regulating PI3K/AKT/MMP7 signaling pathway,” Biochemical and Biophysical Research Communications, vol. 470, no. 2, pp. 397–404, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. S.-J. Yang, C.-Y. Chen, G.-D. Chang et al., “Activation of akt by advanced glycation end products (AGEs): involvement of IGF-1 receptor and caveolin-1,” PLoS ONE, vol. 8, no. 3, Article ID e58100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Huang and X. Du, “Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination,” World Journal of Gastroenterology, vol. 14, no. 12, pp. 1823–1827, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Wu and B. P. Zhou, “Inflammation: a driving force speeds cancer metastasis,” Cell Cycle, vol. 8, no. 20, pp. 3267–3273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. R. Hayden, S. C. Tyagi, L. Kolb, J. R. Sowers, and R. Khanna, “Vascular ossification—calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis—calcific uremic arteriolopathy: the emerging role of sodium thiosulfate,” Cardiovascular Diabetology, vol. 4, article 4, 2005. View at Publisher · View at Google Scholar · View at Scopus